"Understanding biological variation in Alzheimer's disease plasma biomarkers is crucial for accurate interpretation of individual-level data. As blood biomarkers become increasingly integral to diagnosis and monitoring, characterizing their variability is essential to distinguish pathological changes from normal fluctuations, thereby improving personalized medicine approaches for Alzheimer's disease patients (2023)."